ALMS

Alumis Inc. - Common Stock (ALMS)

About Alumis Inc. - Common Stock (ALMS)

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.

Details

Daily high

$6.75

Daily low

$6.61

Price at open

$6.66

52 Week High

$31.35

52 Week Low

$4.28

Market cap

903.8M

Dividend yield

Volume

109,614

Avg. volume

3.0M

P/E ratio

-1.78

Alumis Inc. - Common Stock News